Calliditas

Asahi Kasei to buy Swedish drugmaker Calliditas for US.1 billion
Asahi Kasei to buy Swedish drugmaker Calliditas for US$1.1 billion
Japan’s Asahi Kasei said on Tuesday (May 28) it offered to acquire Calliditas Therapeutics for about US$1.1 billion as part of a plan to become a global drug company.The...